Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Zohlnhöfer D[au]:

Protective Function of Ahnak1 in Vascular Healing after Wire Injury. Haase N et al. J Vasc Res. (2017)

In vivo biocompatibility assessment of poly (ether imide) electrospun scaffolds. Haase T et al. J Tissue Eng Regen Med. (2017)

Combinatorial G-CSF/AMD3100 treatment in cardiac repair after myocardial infarction. Rüder C et al. PLoS One. (2014)

Search results

Items: 33

1.

Protective Function of Ahnak1 in Vascular Healing after Wire Injury.

Haase N, Rüder C, Haase H, Kamann S, Kouno M, Morano I, Dechend R, Zohlnhöfer D, Haase T.

J Vasc Res. 2017;54(3):131-142. doi: 10.1159/000464287. Epub 2017 May 4.

PMID:
28468000
2.

In vivo biocompatibility assessment of poly (ether imide) electrospun scaffolds.

Haase T, Krost A, Sauter T, Kratz K, Peter J, Kamann S, Jung F, Lendlein A, Zohlnhöfer D, Rüder C.

J Tissue Eng Regen Med. 2017 Apr;11(4):1034-1044. doi: 10.1002/term.2002. Epub 2015 Feb 25.

PMID:
25712330
3.

Combinatorial G-CSF/AMD3100 treatment in cardiac repair after myocardial infarction.

Rüder C, Haase T, Krost A, Langwieser N, Peter J, Kamann S, Zohlnhöfer D.

PLoS One. 2014 Aug 14;9(8):e104644. doi: 10.1371/journal.pone.0104644. eCollection 2014.

4.

Influence of fibre diameter and orientation of electrospun copolyetheresterurethanes on smooth muscle and endothelial cell behaviour.

Rüder C, Sauter T, Kratz K, Haase T, Peter J, Jung F, Lendlein A, Zohlnhöfer D.

Clin Hemorheol Microcirc. 2013 Jan 1;55(4):513-22. doi: 10.3233/CH-131787.

PMID:
24113506
5.

Smooth muscle and endothelial cell behaviour on degradable copolyetheresterurethane films.

Rüder C, Sauter T, Kratz K, Peter J, Jung F, Lendlein A, Zohlnhöfer D.

Clin Hemorheol Microcirc. 2012;52(2-4):313-23. doi: 10.3233/CH-2012-1607.

PMID:
22975944
6.

Viability, proliferation and adhesion of smooth muscle cells and human umbilical vein endothelial cells on electrospun polymer scaffolds.

Rüder C, Sauter T, Becker T, Kratz K, Hiebl B, Jung F, Lendlein A, Zohlnhöfer D.

Clin Hemorheol Microcirc. 2012;50(1-2):101-12. doi: 10.3233/CH-2011-1447.

PMID:
22538539
7.

Coronary stenting after myocardial infarction during twin pregnancy--a case report.

von Steinburg SP, Klein E, Langwieser N, Kastrati A, Schneider KT, Zohlnhöfer D.

Hypertens Pregnancy. 2011;30(4):485-9. doi: 10.3109/10641955.2010.486457. Epub 2010 Sep 6.

PMID:
20818969
8.

Expression of CXCR4, VLA-1, LFA-3 and transducer of ERB in G-CSF-mobilised progenitor cells in acute myocardial infarction.

Stein A, Zohlnhöfer D, Pogatsa-Murray G, von Wedel J, Steppich BA, Schömig A, Kastrati A, Ott I.

Thromb Haemost. 2010 Mar;103(3):638-43. doi: 10.1160/TH09-09-0657. Epub 2010 Jan 13.

PMID:
20076856
9.

Role of bone marrow-derived cells in the genetic control of restenosis.

Langwieser N, Schwarz JB, Reichenbächer C, Stemmer B, Massberg S, Langwieser NN, Zohlnhöfer D.

Arterioscler Thromb Vasc Biol. 2009 Oct;29(10):1551-7. doi: 10.1161/ATVBAHA.109.188326. Epub 2009 Jul 30.

PMID:
19644054
10.

Novel role of the CXC chemokine receptor 3 in inflammatory response to arterial injury: involvement of mTORC1.

Schwarz JB, Langwieser N, Langwieser NN, Bek MJ, Seidl S, Eckstein HH, Lu B, Schömig A, Pavenstädt H, Zohlnhöfer D.

Circ Res. 2009 Jan 30;104(2):189-200. doi: 10.1161/CIRCRESAHA.108.182683. Epub 2008 Dec 4. Retraction in: Circ Res. 2011 May 27;108(11):e14.

PMID:
19059841
11.

Myocardial gene expression of matched hibernating and control tissue from patients with ischemic left ventricular dysfunction.

Zohlnhöfer D, Nührenberg TG, Haas F, Bengel F, Schömig A, Baeuerle PA, Schwaiger M.

Heart Vessels. 2008 Jul;23(4):230-42. doi: 10.1007/s00380-007-1035-4. Epub 2008 Jul 23.

PMID:
18649053
12.

G-CSF for left ventricular recovery after myocardial infarction: is it time to face reality?

Zohlnhöfer D.

Cardiovasc Drugs Ther. 2008 Oct;22(5):343-5. doi: 10.1007/s10557-008-6114-y. Epub 2008 May 23. No abstract available.

PMID:
18498047
13.

Gene expression analysis of a single or few cells.

Klein CA, Zohlnhöfer D, Petat-Dutter K, Wendler N.

Curr Protoc Hum Genet. 2005 Feb;Chapter 11:Unit 11.8. doi: 10.1002/0471142905.hg1108s44.

PMID:
18428372
14.

Stem cell mobilization by granulocyte colony-stimulating factor for myocardial recovery after acute myocardial infarction: a meta-analysis.

Zohlnhöfer D, Dibra A, Koppara T, de Waha A, Ripa RS, Kastrup J, Valgimigli M, Schömig A, Kastrati A.

J Am Coll Cardiol. 2008 Apr 15;51(15):1429-37. doi: 10.1016/j.jacc.2007.11.073.

15.

Gene expression analysis of a single or few cells.

Klein CA, Zohlnhöfer D, Petat-Dutter K, Wendler N.

Curr Protoc Mol Biol. 2003 Feb;Chapter 25:Unit 25B.8. doi: 10.1002/0471142727.mb25b08s61.

PMID:
18265324
16.

EMAP-II downregulation contributes to the beneficial effects of rapamycin after vascular injury.

Nührenberg TG, Langwieser N, Schwarz JB, Hou Y, Frank P, Sorge F, Matschurat S, Seidl S, Kastrati A, Schömig A, Clauss MA, Zohlnhöfer D.

Cardiovasc Res. 2008 Feb 1;77(3):580-9. Epub 2007 Nov 20.

PMID:
18029408
17.

Stem cell mobilization by granulocyte-colony-stimulating factor in acute myocardial infarction: lessons from the REVIVAL-2 trial.

Zohlnhöfer D, Kastrati A, Schömig A.

Nat Clin Pract Cardiovasc Med. 2007 Feb;4 Suppl 1:S106-9.

PMID:
17230206
18.

Stem cell mobilization by granulocyte colony-stimulating factor in patients with acute myocardial infarction: a randomized controlled trial.

Zohlnhöfer D, Ott I, Mehilli J, Schömig K, Michalk F, Ibrahim T, Meisetschläger G, von Wedel J, Bollwein H, Seyfarth M, Dirschinger J, Schmitt C, Schwaiger M, Kastrati A, Schömig A; REVIVAL-2 Investigators.

JAMA. 2006 Mar 1;295(9):1003-10.

PMID:
16507801
19.

A randomized, double-blind, placebo-controlled trial on restenosis prevention by the receptor tyrosine kinase inhibitor imatinib.

Zohlnhöfer D, Hausleiter J, Kastrati A, Mehilli J, Goos C, Schühlen H, Pache J, Pogatsa-Murray G, Heemann U, Dirschinger J, Schömig A.

J Am Coll Cardiol. 2005 Dec 6;46(11):1999-2003. Epub 2005 Nov 4.

20.

Randomized evaluation of the effects of filter-based distal protection on myocardial perfusion and infarct size after primary percutaneous catheter intervention in myocardial infarction with and without ST-segment elevation.

Gick M, Jander N, Bestehorn HP, Kienzle RP, Ferenc M, Werner K, Comberg T, Peitz K, Zohlnhöfer D, Bassignana V, Buettner HJ, Neumann FJ.

Circulation. 2005 Sep 6;112(10):1462-9. Epub 2005 Aug 29.

PMID:
16129793
21.

Vascular remodeling in mice lacking the cytoplasmic domain of tissue factor.

Ott I, Michaelis C, Schuermann M, Steppich B, Seitz I, Dewerchin M, Zohlnhofer D, Wessely R, Rudelius M, Schömig A, Carmeliet P.

Circ Res. 2005 Aug 5;97(3):293-8. Epub 2005 Jul 14.

PMID:
16020755
22.

Rapamycin attenuates vascular wall inflammation and progenitor cell promoters after angioplasty.

Nührenberg TG, Voisard R, Fahlisch F, Rudelius M, Braun J, Gschwend J, Kountides M, Herter T, Baur R, Hombach V, Baeuerle PA, Zohlnhöfer D.

FASEB J. 2005 Feb;19(2):246-8. Epub 2004 Nov 16.

PMID:
15546959
23.

Randomized, double-blind, placebo-controlled trial of oral sirolimus for restenosis prevention in patients with in-stent restenosis: the Oral Sirolimus to Inhibit Recurrent In-stent Stenosis (OSIRIS) trial.

Hausleiter J, Kastrati A, Mehilli J, Vogeser M, Zohlnhöfer D, Schühlen H, Goos C, Pache J, Dotzer F, Pogatsa-Murray G, Dirschinger J, Heemann U, Schömig A; OSIRIS Investigators.

Circulation. 2004 Aug 17;110(7):790-5. Epub 2004 Aug 9.

PMID:
15302787
24.

Rapamycin effects transcriptional programs in smooth muscle cells controlling proliferative and inflammatory properties.

Zohlnhöfer D, Nührenberg TG, Neumann FJ, Richter T, May AE, Schmidt R, Denker K, Clauss MA, Schömig A, Baeuerle PA.

Mol Pharmacol. 2004 Apr;65(4):880-9.

PMID:
15044617
25.

A crucial role of glycoprotein VI for platelet recruitment to the injured arterial wall in vivo.

Massberg S, Gawaz M, Grüner S, Schulte V, Konrad I, Zohlnhöfer D, Heinzmann U, Nieswandt B.

J Exp Med. 2003 Jan 6;197(1):41-9.

26.

Transcriptome analysis reveals a role of interferon-gamma in human neointima formation.

Zohlnhöfer D, Richter T, Neumann F, Nührenberg T, Wessely R, Brandl R, Murr A, Klein CA, Baeuerle PA.

Mol Cell. 2001 May;7(5):1059-69.

27.

Gene expression profiling of human stent-induced neointima by cDNA array analysis of microscopic specimens retrieved by helix cutter atherectomy: Detection of FK506-binding protein 12 upregulation.

Zohlnhöfer D, Klein CA, Richter T, Brandl R, Murr A, Nührenberg T, Schömig A, Baeuerle PA, Neumann FJ.

Circulation. 2001 Mar 13;103(10):1396-402.

PMID:
11245643
28.

Adhesion of monocyte very late antigen-4 to endothelial vascular cell adhesion molecule-1 induces interleukin-1beta-dependent expression of interleukin-6 in endothelial cells.

Zohlnhöfer D, Brand K, Schipek K, Pogatsa-Murray G, Schömig A, Neumann FJ.

Arterioscler Thromb Vasc Biol. 2000 Feb;20(2):353-9.

PMID:
10669630
29.
30.

Effect of glycoprotein IIb-IIIa receptor antagonism on platelet membrane glycoproteins after coronary stent placement.

Gawaz M, Ruf A, Neumann FJ, Pogátsa-Murray G, Dickfeld T, Zohlnhöfer D, Schömig A.

Thromb Haemost. 1998 Dec;80(6):994-1001.

PMID:
9869173
31.

Enhancement of monocyte procoagulant activity by adhesion on vascular smooth muscle cells and intercellular adhesion molecule-1-transfected Chinese hamster ovary cells.

Marx N, Neumann FJ, Zohlnhöfer D, Dickfeld T, Fischer A, Heimerl S, Schömig A.

Circulation. 1998 Sep 1;98(9):906-11.

PMID:
9738646
32.

The hepatic interleukin-6 receptor. Studies on its structure and regulation by phorbol 12-myristate 13-acetate-dexamethasone.

Pietzko D, Zohlnhöfer D, Graeve L, Fleischer D, Stoyan T, Schooltink H, Rose-John S, Heinrich PC.

J Biol Chem. 1993 Feb 25;268(6):4250-8.

33.

The hepatic interleukin-6 receptor. Down-regulation of the interleukin-6 binding subunit (gp80) by its ligand.

Zohlnhöfer D, Graeve L, Rose-John S, Schooltink H, Dittrich E, Heinrich PC.

FEBS Lett. 1992 Jul 20;306(2-3):219-22.

Supplemental Content

Loading ...
Support Center